GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma

[1]  Y. Pommier,et al.  SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243 , 2021, Cancer Research.

[2]  T. Ketela,et al.  A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity , 2021, JCI insight.

[3]  Dai-yan Fu,et al.  CHOP overexpression sensitizes human non-small cell lung cancer cells to cisplatin treatment by Bcl-2/JNK pathway. , 2021, American journal of translational research.

[4]  A. Schimmer,et al.  E1 Enzymes as Therapeutic Targets in Cancer , 2021, Pharmacological Reviews.

[5]  W. Yung,et al.  Molecular Mechanisms of Treatment Resistance in Glioblastoma , 2020, International journal of molecular sciences.

[6]  E. J. Song,et al.  Ubiquitin–proteasome system (UPS) as a target for anticancer treatment , 2020, Archives of Pharmacal Research.

[7]  Hui Luo,et al.  Targeting the GRP78 Pathway for Cancer Therapy , 2020, Frontiers in Medicine.

[8]  N. Neamati,et al.  UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer , 2020, Translational oncology.

[9]  A. Papavassiliou,et al.  Targeting of Endoplasmic Reticulum (ER) Stress in Gliomas. , 2020, Pharmacological research.

[10]  S. Linder,et al.  Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers , 2020, Cancers.

[11]  Dayong Yang,et al.  Glioblastoma precision therapy: From the bench to the clinic. , 2020, Cancer letters.

[12]  Fenglei Chen,et al.  Endoplasmic Reticulum Stress Cooperates in Silica Nanoparticles-Induced Macrophage Apoptosis via Activation of CHOP-Mediated Apoptotic Signaling Pathway , 2019, International journal of molecular sciences.

[13]  Yuning Lin,et al.  Cancer and ER stress: Mutual crosstalk between autophagy, oxidative stress and inflammatory response. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  Jiahui Tao,et al.  Endoplasmic Reticulum Stress Signaling Pathways: Activation and Diseases. , 2019, Current protein & peptide science.

[15]  Junghwan Lee,et al.  Reactive oxygen species‐mediated endoplasmic reticulum stress response induces apoptosis of Mycobacterium avium‐infected macrophages by activating regulated IRE1‐dependent decay pathway , 2019, Cellular microbiology.

[16]  Cem Kuscu,et al.  CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia , 2019, Oncotarget.

[17]  Shangfeng Gao,et al.  The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma , 2019, Journal of Experimental & Clinical Cancer Research.

[18]  Xuling Lin,et al.  Targeted Therapies for the Treatment of Glioblastoma in Adults , 2019, Current Oncology Reports.

[19]  Kai Wang,et al.  Endoplasmic reticulum proteostasis control and gastric cancer. , 2019, Cancer letters.

[20]  Ibrahim M. Ibrahim,et al.  GRP78: A cell's response to stress , 2019, Life Sciences.

[21]  R. Davis,et al.  Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma. , 2019, Blood.

[22]  M. Minden,et al.  Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia , 2018, Leukemia.

[23]  S. Tirrell,et al.  A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment , 2018, Nature Medicine.

[24]  C. Hetz,et al.  The Unfolded Protein Response and Cell Fate Control. , 2017, Molecular cell.

[25]  J. Diehl,et al.  Recent insights into PERK-dependent signaling from the stressed endoplasmic reticulum , 2017, F1000Research.

[26]  T. Oyama,et al.  Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma. , 2017, Cancer biomarkers : section A of Disease markers.

[27]  Wei-Yu Tang,et al.  GRP78 silencing enhances hyperoxia-induced alveolar epithelial cell apoptosis via CHOP pathway. , 2017, Molecular medicine reports.

[28]  K. Ligon,et al.  Glioblastoma targeted therapy: updated approaches from recent biological insights , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  Y. Tomizawa,et al.  High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma , 2017, International Journal of Clinical Oncology.

[30]  C. Hetz,et al.  Endoplasmic reticulum proteostasis in glioblastoma—From molecular mechanisms to therapeutic perspectives , 2017, Science Signaling.

[31]  Shangfeng Gao,et al.  CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways , 2016, Journal of Hematology & Oncology.

[32]  C. Hetz,et al.  ER proteostasis addiction in cancer biology: Novel concepts. , 2015, Seminars in cancer biology.

[33]  P. Walter,et al.  The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation , 2011, Science.

[34]  G. Riggins,et al.  Molecular targeting of glioblastoma: Drug discovery and therapies. , 2011, Trends in molecular medicine.

[35]  J. Moffat,et al.  The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma. , 2010, Blood.